Bio-Rad Laboratories, Inc.Class A

BIONYSE • USD
361.52 USD
↘ 16.20 (4.29%)🟢LIVE (AS OF 12:48 PM EDT)
🟢Market: OPEN

Bio-Rad Laboratories, Inc.Class A (BIO) is currently trading at $361.52. Our models show a "Neutral" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score and a bullish Golden Cross on the moving averages. On valuation, BIO trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Sep 30, 2026.

Open?$373.87
High?$379.83
Low?$361.20
Prev. Close?$377.71
Volume?102.2K
Avg. Volume?272.1K
VWAP?$368.45
Rel. Volume?0.38x
Bid / Ask
Bid?$361.42 × 40
Ask?$362.90 × 40
Spread?$1.48
Midpoint?$362.16
Valuation & Ratios
Market Cap?10.1B
Shares Out?21.7M
Float?18.5M
Float %?85.2%
P/E Ratio?45.41
P/B Ratio?1.41
EPS?$8.32
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Employees
7.5K
Market Cap
10.1B
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
1980-02-29
Address
1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547
Phone: (510) 724-7000
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
86
Momentum?
48
Short Sent.?
74
Piotroski F-Score?5/9Mixed
Altman Z-Score?3.63Safe
Confidence?74%Moderate
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.41%Elevated
Short Interest?998.7K
Days to Cover?3.8
Free Float18.5M
Avg Daily Volume261.0K
Settlement Date2026-09-15
Financial Health
Current Ratio?3.14Strong
Quick Ratio?2.33Strong
Cash Ratio?0.54Adequate
Debt/Equity?0.17Low
ValuationFAIRLY VALUEDvs 9 peers + S&P 500
Score
61/100
P/E?
Peers
50
S&P
15
45.4PRICEY▾
P/B?
Peers
100
S&P
89
1.41CHEAP▾
P/S?
Peers
90
S&P
39
3.90FAIR▾
P/FCF?
Peers
80
S&P
32
28.6FAIR▾
EV/EBITDA?
Peers
20
S&P
3
47.8HIGH▾
EV/Sales?
Peers
90
S&P
45
4.17FAIR▾
Returns & Efficiency
ROE?
Peers
20
S&P
18
3.1%WEAK▾
ROA?
Peers
30
S&P
21
2.2%WEAK▾
Cash Flow & Enterprise
FCF?$353.1M
Enterprise Value?$10.8B
Fundamentals ratios updated end of day